News
The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...
Walmart's valuation may be overhyped amidst industry headwinds and risks like SNAP cuts, tariffs, and shifting consumer ...
The GLP-1 arena has turned into a boxing match between heavyweights Novo Nordisk and Eli Lilly as the two pharma giants ...
Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, ...
GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.
See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!
Rybelsus, the oral form of Semaglutide launched by Novo Nordisk in January 2022, has grown from Rs 26 crore to Rs 412 crore, ...
A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
Theratechnologies entered a definitive agreement to be acquired by Future Pak. Find out why do not expect to see THTX stock ...
H ealth officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results